Chalmers, in-company, engaged in research in cancer, 22 million of the state fund of the

Together with the business incubator, Chalmers Ventures, who have supported the company from its inception in may Elypta a total of 64,8 million euro, of which eur 22 million from the industrial development fund.

" It's a very important indication of a company such as ours. We are also going to need more funding in the future. We are working towards being able to reach the market and patients in 2022, " says the Elyptas managing director, Karl M., to the ROTOR.

as of the breakthroughs that dr. Francesco Gatto believes he has achieved under the leadership of professor Jens Nielsen at Chalmers university of technology systembiologilabb. He and Gatto is the co-founder of the Elypta.

the Company is attempting to develop a method that is designed to provide early detection and follow-up of cancer of the kidney. There is a clinical study conducted in six different countries, and the production of the test kits in the united states.

president and Ceo, Karl Bergman, said that on the basis of a urine test to measure the levels of a number of substances, which, according to the researchers, the relevance of the presence of cancer. If the test proves successful, they hope to be able to be used for other types of cancer.

it is deemed an important in order to attract the interest of the not the least, investors in the us.

so far, it has been Elypta, with only seven full-time employees, but the plan now is to grow the business. The company leases the premises of the Chalmers university of technology in Gothenburg, sweden, and the conduct of clinical trials is carried out in the Area. The company's registered office is also at Gothenburg, sweden, but the majority of the employees in the premises of KTH in Stockholm, sweden.

for dagens nyheter, wrote in november, criticism of what the West sweden chamber of commerce is perceived as a lack of interest on the part of the industrial development fund for investments in the Gothenburg region. Industrifonden's Jonas Jendi, who is responsible for the investment in the project at the Chalmers university of technology, said that he was aware of the discussion.

" But it has not played a role in the decision on the Elypta. We had our first meeting with them in October of 2017, and it will take time to put together all of the elements of such a deal.